298 related articles for article (PubMed ID: 24809875)
1. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
Saco M; Thigpen J
J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of biopsy method on the quality of surgical management in melanoma.
Kaiser S; Vassell R; Pinckney RG; Holmes TE; James TA
J Surg Oncol; 2014 Jun; 109(8):775-9. PubMed ID: 24862925
[TBL] [Abstract][Full Text] [Related]
3. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
Mills JK; White I; Diggs B; Fortino J; Vetto JT
Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
[TBL] [Abstract][Full Text] [Related]
4. Clinical Impact and Accuracy of Shave Biopsy for Initial Diagnosis of Cutaneous Melanoma.
Jones S; Henry V; Strong E; Sheriff SA; Wanat K; Kasprzak J; Clark M; Shukla M; Zenga J; Stadler M; Dzwierzynski W; Harker-Murray A; Young K; Kothari AN; Clarke CN
J Surg Res; 2023 Jun; 286():35-40. PubMed ID: 36739830
[TBL] [Abstract][Full Text] [Related]
5. Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth?
Ng PC; Barzilai DA; Ismail SA; Averitte RL; Gilliam AC
J Am Acad Dermatol; 2003 Mar; 48(3):420-4. PubMed ID: 12637923
[TBL] [Abstract][Full Text] [Related]
6. Method of biopsy and incidence of positive margins in primary melanoma.
Stell VH; Norton HJ; Smith KS; Salo JC; White RL
Ann Surg Oncol; 2007 Feb; 14(2):893-8. PubMed ID: 17119869
[TBL] [Abstract][Full Text] [Related]
7. Shave biopsy is a safe and accurate method for the initial evaluation of melanoma.
Zager JS; Hochwald SN; Marzban SS; Francois R; Law KM; Davis AH; Messina JL; Vincek V; Mitchell C; Church A; Copeland EM; Sondak VK; Grobmyer SR
J Am Coll Surg; 2011 Apr; 212(4):454-60; discussion 460-2. PubMed ID: 21463767
[TBL] [Abstract][Full Text] [Related]
8. The impact of shave biopsy on the management of patients with thin melanomas.
Lowe M; Hill N; Page A; Chen S; Delman KA
Am Surg; 2011 Aug; 77(8):1050-3. PubMed ID: 21944522
[TBL] [Abstract][Full Text] [Related]
9. Does shave biopsy accurately predict the final breslow depth of primary cutaneous melanoma?
Moore P; Hundley J; Hundley J; Levine EA; Williford P; Sangueza O; McCoy T; Shen P
Am Surg; 2009 May; 75(5):369-73; discussion 374. PubMed ID: 19445285
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of partial biopsies in the management of cutaneous melanoma.
Doolan BJ; Robinson AJ; Wolfe R; Kelly JW; McLean C; McCormack C; Henderson MA; Pan Y
Australas J Dermatol; 2019 Aug; 60(3):209-213. PubMed ID: 30773625
[TBL] [Abstract][Full Text] [Related]
11. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
12. Biopsy for malignant melanoma--are we following the guidelines?
Tadiparthi S; Panchani S; Iqbal A
Ann R Coll Surg Engl; 2008 May; 90(4):322-5. PubMed ID: 18492398
[TBL] [Abstract][Full Text] [Related]
13. A comparison of current practice patterns of US dermatologists versus published guidelines for the biopsy, initial management, and follow up of patients with primary cutaneous melanoma.
Farberg AS; Rigel DS
J Am Acad Dermatol; 2016 Dec; 75(6):1193-1197.e1. PubMed ID: 27742167
[TBL] [Abstract][Full Text] [Related]
14. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous malignant melanoma: a primary care perspective.
Shenenberger DW
Am Fam Physician; 2012 Jan; 85(2):161-8. PubMed ID: 22335216
[TBL] [Abstract][Full Text] [Related]
16. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
17. The increasing use of shave biopsy for diagnosing invasive melanoma in Australia.
de Menezes SL; Kelly JW; Wolfe R; Farrugia H; Mar VJ
Med J Aust; 2019 Sep; 211(5):213-218. PubMed ID: 31328802
[TBL] [Abstract][Full Text] [Related]
18. The impact of partial biopsy on histopathologic diagnosis of cutaneous melanoma: experience of an Australian tertiary referral service.
Ng JC; Swain S; Dowling JP; Wolfe R; Simpson P; Kelly JW
Arch Dermatol; 2010 Mar; 146(3):234-9. PubMed ID: 20231492
[TBL] [Abstract][Full Text] [Related]
19. Symptoms and signs of primary melanoma: important indicators of Breslow depth.
Negin BP; Riedel E; Oliveria SA; Berwick M; Coit DG; Brady MS
Cancer; 2003 Jul; 98(2):344-8. PubMed ID: 12872355
[TBL] [Abstract][Full Text] [Related]
20. The impact of biopsy technique on upstaging, residual disease, and outcome in cutaneous melanoma.
Egnatios GL; Dueck AC; Macdonald JB; Laman SD; Warschaw KE; DiCaudo DJ; Nemeth SA; Sekulic A; Gray RJ; Wasif N; Pockaj BA
Am J Surg; 2011 Dec; 202(6):771-7; discussion 777-8. PubMed ID: 22000117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]